Navigation Links
Senior Executive to Share Views On Physician Payment Sunshine Provisions

ELLICOTT CITY, Md., June 15, 2011 /PRNewswire/ -- Adam Chasse, vice president for business development at RxTrials, Inc., will participate in a presentation on Capitol Hill this Friday, June 17, regarding the Physician Payment Sunshine provisions of the health care reform legislation passed last year. Chasse will join representatives of the Association of Clinical Research Organizations (ACRO) and other industry stakeholders in the briefing for legislative staffers.

The Physician Payment Sunshine provisions were part of the Patient Protection and Affordable Care Act signed into law on March 23, 2010. The provisions require drug and medical device manufacturers to publicly report gifts and payments of more than $10 made to physicians and teaching hospitals. Examples of what must be reported include stock options, consulting fees, travel and lodging for conferences, honoraria, and research funding or grants. Reporting is to begin for payments in the 2012 calendar year. The information is to be fully reported by March 31, 2013, and posted in a searchable database starting September 30, 2013.

It is the opinion of Chasse and other clinical research industry professionals that disclosing payments made to physicians who serve as principal investigators for clinical research adds great cost and complexity to research & development for relatively small benefit.

"Research grants differ from consulting fees in that they are intended to cover the very real costs providers incur when conducting clinical research; average profit margins are minimal, so grants are unlikely to entice physicians to write more prescriptions for the pharma company's drug," Chasse said. "Plus, grants typically flow through one or more intermediaries such as a CRO, research management company, or university, making it very difficult to quantify what the physician actually receives. Our goal on Friday is to explain the challenges these provisions present to our industry."


RxTrials, Inc., is a network of premier clinical research sites and parent company of RxTrials Institute, a leading national clinical research consultant and education provider. RxTrials Institute each year presents the Site Solutions Summit, a top networking and business management conference for clinical research sites, sponsors and CROs. The Summit takes place this year October 14 – 16 in Palm Beach Gardens, Florida (

SOURCE RxTrials, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk
2. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
3. Seniors Can Be Heartened by New Study on Statins
4. VELOCITY Broadcasting Appoints Senior Director of Strategic Business Development
5. Curemark Announces Senior Executive Promotions
6. HealthCare Partners, IPA, Dr. Richard Merkin, CEO, Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington, DC
7. EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales
8. Par Pharmaceutical Announces Modified Dutch Auction Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010
9. National Long Term Care Leaders Praise Senator Snowes Recognition of Nursing Homes Unique Funding Challenges in Caring for Nations Seniors
10. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
11. University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales
Post Your Comments:
(Date:11/26/2015)... Bajos, November 26, 2015 Un ... de Bremachlorin para el cáncer avanzado.   ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Cancer Research . --> Clinical Cancer Research ...
(Date:11/26/2015)... , November 26, 2015 --> ... to use SyMRI to find optimal contrast weighting of MRI ... metastases, and has signed a research agreement with SyntheticMR in ... hospital. Using SyMRI, it is possible to generate multiple contrast ... after the patient has left, thus making it possible to ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has released ... Surviving Mesothelioma has just posted the findings on the website. Click here to ... cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP surgery. ...
(Date:11/27/2015)... ... 27, 2015 , ... The print component of “Supporting Our ... Dallas, New York, Minneapolis, South Florida, with a circulation of approximately 250,000 copies ... a vast social media strategy and across a network of top news sites ...
(Date:11/27/2015)... DE (PRWEB) , ... November 27, 2015 , ... ... member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s ... an independent group of Microsoft Dynamics SL software users, partners, industry experts and ...
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and distributor ... Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. , ... up-to-date with a version of Asterisk that will receive not only security fixes, ...
Breaking Medicine News(10 mins):